A spinout from PsychoGenics Inc, Axelyra is a well-funded, biotech startup focused on unmet needs in psychiatric and neurological disorders. We leverage proprietary preclinical platforms and AI-driven analytics spanning both clinical and preclinical behavioral and electrophysiological (EEG) phenotyping to enable a compound re-innovation strategy. We are building AI-enabled platforms that support clinical development, including tools and models that help quantify treatment response, stratify patients, and accelerate learning across trials. Our work is highly multidisciplinary, with day-to-day collaboration across data science/engineering, biologists, translational scientists, and clinicians. PsychoGenics is a preclinical CRO with expertise in central nervous system (CNS) and orphan disorders. PsychoGenics is known for its cutting-edge translational approach to research, customized solutions, the breadth, and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help clients quantify the efficacy of their treatments. With an extensive portfolio of highly predictive disease models and unparalleled experience performing studies for biopharmaceutical companies of all sizes, we enable clients to deliver much needed superior clinical candidates to patients.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level